John B Moriarty Mirati Therapeutics, Inc. (MRTX) insider trading activity

MRTX Quotes by TradingView

John B Moriarty is Chief Legal Officer of Mirati Therapeutics, Inc.. Currently has a direct ownership of 0 shares of MRTX, which is worth approximately $0. The most recent transaction as insider was on Jan 23, 2024, when has been sold 72,335 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

John B Moriarty Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 23 2024
SELL
Sale (or disposition) back to the issuer
-
72,335 Reduced 100.0%
0 Common Stock
Aug 09 2023
BUY
Grant, award, or other acquisition
$824,989 $37.0 p/Share
22,297 Added 23.73%
71,660 Common Stock

Also insider at

OLMA
Olema Pharmaceuticals, Inc. Healthcare
EVP, Ch. Legal Officer & Sec.
RNA
Avidity Biosciences, Inc. Healthcare
Chief Legal Officer
JBM

John B Moriarty

Chief Legal Officer
San Francisco, CA

Track Institutional and Insider Activities on MRTX

Follow Mirati Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRTX shares.

Notify only if

Insider Trading

Get notified when an Mirati Therapeutics, Inc. insider buys or sells MRTX shares.

Notify only if

News

Receive news related to Mirati Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MRTX